Keywords: novo, nordisk, sales, rise, signs, pact, japan
Novo Nordisk sales rise 13%, signs pact with Japan's Takeda
Article | 12 August 1999
Denmark's Novo Nordisk has posted a higher-than-expected 13% rise inconsolidated sales for the first half of 1999, up to 9.86 billion Danish kroner ($1.42 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
